economyDevelopingUpdated 3 d ago · since 22 Sept 2026
Novo Nordisk CEO discusses Ozempic patent expiration
The CEO of Novo Nordisk described the Ozempic patent cliff as the elephant in the room.
How each country tells it
So far our sources show coverage from one country. Perspectives appear once we find reports from a second country.
Sources
Summaries are AI-generated from the linked sources and may contain errors; always check the originals. We summarise and link; we never republish articles. Photos come from openly licensed libraries, official publicity material and brand logos, credited to their sources. If you own an image and want it credited differently or removed, email info@coda.news and we will act promptly.
United States